Drug Trial Radar · NCT07571200
A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Last checked: Nov 20, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
32
Planned (sponsor's estimate)
Start
May 14, 2026
Primary completion
Jun 2029
Study completion Jun 2029
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- May 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Parallel
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study OLMP is a master protocol that will support a collection of individual sub studies that share key design components. Participants from the originator study OWAA (NCT07100119) will be assigned to the appropriate study treatment group: Sporadic Amyotrophic Lateral Sclerosis OL01 (NCT07571174). The studies aim to evaluate the safety and tolerability of different treatments in participants with Amyotrophic Lateral Sclerosis (ALS) that will last at least 96 weeks.
Conditions
- Amyotrophic Lateral Sclerosis
Interventions
LY4256984Drug
Administered IT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Allocated to Each of the Intervention-Specific Appendices (ISA)Time frame: Baseline Up to Week 96
Locations
11 sites in 5 countries. Site status is shown where the registry gives one.
UZ Leuven
Leuven, Belgium · Not yet recruiting
Heritage Medical Research Clinic
Calgary, Canada · Not yet recruiting
University Hospital - London Health Sciences Centre
London, Canada · Not yet recruiting
McGill University Health Centre
Montreal, Canada · Recruiting
Sunnybrook Research Institute
Toronto, Canada · Recruiting
Universitätsklinikum Schleswig-Holstein
Lübeck, Germany · Not yet recruiting
Universitätsmedizin Rostock
Rostock, Germany · Not yet recruiting
Universitaetsklinikum Ulm
Ulm, Germany · Not yet recruiting
Universitair Medisch Centrum Utrecht
Utrecht, Netherlands · Not yet recruiting
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Spain · Not yet recruiting
Hospital Universitari i Politecnic La Fe
Valencia, Spain · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.